| Strong / moderate Recommendation | New 2023 |
|---|---|
| In CVT patients with a low risk of recurrent CVT or extracerebral venous thrombosis, anticoagulation shall be discontinued after 3 (to 12) months. In CVT patients with an increased risk of recurrent CVT or extracerebral venous thrombosis, anticoagulation should be continued in the long term as secondary prophylaxis to prevent VTE recurrences | |
| Consensus 100% | |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.